Bristol Cup Posters
Identifieur interne : 005C47 ( Main/Exploration ); précédent : 005C46; suivant : 005C48Bristol Cup Posters
Auteurs :Source :
- British Journal of Dermatology [ 0007-0963 ] ; 2009-07.
Descripteurs français
- Wicri :
- topic : Audit, Base de données, Histologie, Rage, Maladie de la peau.
English descriptors
- KwdEn :
- Abnormality, Acad, Acad dermatol, Acitretin, Acne, Acral, Adalimumab, Adverse pregnancy outcomes, Allergen, Angioma, Antitumour, Assay, Asymptomatic, Audit, Authors journal compilation, Autoantibody, Autoimmune, Axillary, Azathioprine, Basal, Basal cell carcinoma, Basal cell carcinomas, Baseline, Bccs, Belfast, Benign, Biologics, Biopsy, Birthweight, Botulinum, Breslow, Breslow thickness, Bristol, British association, Bullous, Carcinoma, Cardiff, Cardiff university, Caucasian, Cellulitis, Chaperone, Chronic plaque psoriasis, Chronic skin diseases, Clin, Clinic, Clinical diagnosis, Clinical features, Clinician, Cohort, Complete clearance, Consultant dermatologist, Corticosteroid, Counselling, Cutaneous, Cutaneous disease, Cutaneous lymphoma, Cyld, Database, December, Dermatitis, Dermatol, Dermatological, Dermatologist, Dermatologists british journal, Dermatology, Dermatology department, Dermatology life quality index, Dermatology patients, Dermis, Disease severity, Dlqi, Durham, Eczema, Eczematoid, Edinburgh, Effective treatment, Epidermal, Epidermal naevus, Erythema, Erythematosus, Erythematous, Etanercept, Excision, Fabry, Fabry disease, Family history, Female patients, Gastroenterologist, General population, General practice, General practitioners, Gpwsis, Guideline, Gvhd, Healthcare, Histoid, Histoid leprosy, Histological, Histology, Histopathological, Histopathology, Hsct, Hyperhidrosis, Imiquimod, Inpatient, Iontophoresis, January, July, Keratinocytes, Keratoacanthoma, Leicester, Leprosy, Lesion, Leukaemia, Lupus, Lyell, Lymphocyte, Lymphoid, Lymphoma, Lymphoproliferative, Macular, Male dermatologists, Malignancy, Malignant, Malignant melanoma, Median, Medical education, Melanoma, Methotrexate, Methylation, Mthfr, Mthfr polymorphism, Mucosal, Multidisciplinary, Multiforme, Mutation, Myotonic, Naevus, Nbuvb, Ndings, Neurological, Neurological disease, Newcastle, Nice guidelines, Nmsc, Node, Nonclinical, Noncutaneous, Noncutaneous malignancies, Northern ireland, November, Outpatient, Pasi, Patient information, Pemphigus, Pemphigus vulgaris, Phenotype, Phototherapy, Placebo, Polymorphism, Poster, Practitioner, Primary care, Psoriasis, Psoriasis area, Psoriatic, Pten, Puva, Rabies, Radiotherapy, Randomized, Rapamycin, Receptor, Recurrence, Referral, Registrar, Relapse, Remission, Renal, Responder, Response rate, Retrospective, Retrospective review, Retrospective study, Rheumatoid arthritis, Rheumatologist, Rituximab, Sarcoidosis, Scalp psoriasis, Sccs, Secondary care, Severe psoriasis, Severity index, Skin biopsies, Skin biopsy, Skin cancer, Skin cancers, Skin disease, Skin lesions, Slnb, Sorafenib, Squamous, Squamous cell carcinoma, Study period, Subungual, Suppl, Surgical, Syndrome, Systemic corticosteroid treatment, Tanning, Tomography, Toxin, Transplantation, Tumour, Tyne, Uctd, Ulceration, University hospital, Vasculitis, Vitiligo, Vulgaris, Vulval, Workload.
- Teeft :
- Abnormality, Acad, Acad dermatol, Acitretin, Acne, Acral, Adalimumab, Adverse pregnancy outcomes, Allergen, Angioma, Antitumour, Assay, Asymptomatic, Audit, Authors journal compilation, Autoantibody, Autoimmune, Axillary, Azathioprine, Basal, Basal cell carcinoma, Basal cell carcinomas, Baseline, Bccs, Belfast, Benign, Biologics, Biopsy, Birthweight, Botulinum, Breslow, Breslow thickness, Bristol, British association, Bullous, Carcinoma, Cardiff, Cardiff university, Caucasian, Cellulitis, Chaperone, Chronic plaque psoriasis, Chronic skin diseases, Clin, Clinic, Clinical diagnosis, Clinical features, Clinician, Cohort, Complete clearance, Consultant dermatologist, Corticosteroid, Counselling, Cutaneous, Cutaneous disease, Cutaneous lymphoma, Cyld, Database, December, Dermatitis, Dermatol, Dermatological, Dermatologist, Dermatologists british journal, Dermatology, Dermatology department, Dermatology life quality index, Dermatology patients, Dermis, Disease severity, Dlqi, Durham, Eczema, Eczematoid, Edinburgh, Effective treatment, Epidermal, Epidermal naevus, Erythema, Erythematosus, Erythematous, Etanercept, Excision, Fabry, Fabry disease, Family history, Female patients, Gastroenterologist, General population, General practice, General practitioners, Gpwsis, Guideline, Gvhd, Healthcare, Histoid, Histoid leprosy, Histological, Histology, Histopathological, Histopathology, Hsct, Hyperhidrosis, Imiquimod, Inpatient, Iontophoresis, January, July, Keratinocytes, Keratoacanthoma, Leicester, Leprosy, Lesion, Leukaemia, Lupus, Lyell, Lymphocyte, Lymphoid, Lymphoma, Lymphoproliferative, Macular, Male dermatologists, Malignancy, Malignant, Malignant melanoma, Median, Medical education, Melanoma, Methotrexate, Methylation, Mthfr, Mthfr polymorphism, Mucosal, Multidisciplinary, Multiforme, Mutation, Myotonic, Naevus, Nbuvb, Ndings, Neurological, Neurological disease, Newcastle, Nice guidelines, Nmsc, Node, Nonclinical, Noncutaneous, Noncutaneous malignancies, Northern ireland, November, Outpatient, Pasi, Patient information, Pemphigus, Pemphigus vulgaris, Phenotype, Phototherapy, Placebo, Polymorphism, Poster, Practitioner, Primary care, Psoriasis, Psoriasis area, Psoriatic, Pten, Puva, Rabies, Radiotherapy, Randomized, Rapamycin, Receptor, Recurrence, Referral, Registrar, Relapse, Remission, Renal, Responder, Response rate, Retrospective, Retrospective review, Retrospective study, Rheumatoid arthritis, Rheumatologist, Rituximab, Sarcoidosis, Scalp psoriasis, Sccs, Secondary care, Severe psoriasis, Severity index, Skin biopsies, Skin biopsy, Skin cancer, Skin cancers, Skin disease, Skin lesions, Slnb, Sorafenib, Squamous, Squamous cell carcinoma, Study period, Subungual, Suppl, Surgical, Syndrome, Systemic corticosteroid treatment, Tanning, Tomography, Toxin, Transplantation, Tumour, Tyne, Uctd, Ulceration, University hospital, Vasculitis, Vitiligo, Vulgaris, Vulval, Workload.
Url:
DOI: 10.1111/j.1365-2133.2009.09126.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 007B84
- to stream Istex, to step Curation: 007B84
- to stream Istex, to step Checkpoint: 002324
- to stream Main, to step Merge: 005D11
- to stream Main, to step Curation: 005C47
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Bristol Cup Posters</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FA24BE2210FD3154DF6E107C23D2011EB826248A</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1111/j.1365-2133.2009.09126.x</idno>
<idno type="url">https://api.istex.fr/document/FA24BE2210FD3154DF6E107C23D2011EB826248A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">007B84</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">007B84</idno>
<idno type="wicri:Area/Istex/Curation">007B84</idno>
<idno type="wicri:Area/Istex/Checkpoint">002324</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002324</idno>
<idno type="wicri:Area/Main/Merge">005D11</idno>
<idno type="wicri:Area/Main/Curation">005C47</idno>
<idno type="wicri:Area/Main/Exploration">005C47</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Bristol Cup Posters</title>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="sub">Abstracts of the 89th Annual Meeting of the British Association of Dermatologists, 7‐10 July 2009, Glasgow, UK</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint><biblScope unit="vol">161</biblScope>
<biblScope unit="page" from="21">21</biblScope>
<biblScope unit="page" to="69">69</biblScope>
<biblScope unit="page-count">49</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2009-07">2009-07</date>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abnormality</term>
<term>Acad</term>
<term>Acad dermatol</term>
<term>Acitretin</term>
<term>Acne</term>
<term>Acral</term>
<term>Adalimumab</term>
<term>Adverse pregnancy outcomes</term>
<term>Allergen</term>
<term>Angioma</term>
<term>Antitumour</term>
<term>Assay</term>
<term>Asymptomatic</term>
<term>Audit</term>
<term>Authors journal compilation</term>
<term>Autoantibody</term>
<term>Autoimmune</term>
<term>Axillary</term>
<term>Azathioprine</term>
<term>Basal</term>
<term>Basal cell carcinoma</term>
<term>Basal cell carcinomas</term>
<term>Baseline</term>
<term>Bccs</term>
<term>Belfast</term>
<term>Benign</term>
<term>Biologics</term>
<term>Biopsy</term>
<term>Birthweight</term>
<term>Botulinum</term>
<term>Breslow</term>
<term>Breslow thickness</term>
<term>Bristol</term>
<term>British association</term>
<term>Bullous</term>
<term>Carcinoma</term>
<term>Cardiff</term>
<term>Cardiff university</term>
<term>Caucasian</term>
<term>Cellulitis</term>
<term>Chaperone</term>
<term>Chronic plaque psoriasis</term>
<term>Chronic skin diseases</term>
<term>Clin</term>
<term>Clinic</term>
<term>Clinical diagnosis</term>
<term>Clinical features</term>
<term>Clinician</term>
<term>Cohort</term>
<term>Complete clearance</term>
<term>Consultant dermatologist</term>
<term>Corticosteroid</term>
<term>Counselling</term>
<term>Cutaneous</term>
<term>Cutaneous disease</term>
<term>Cutaneous lymphoma</term>
<term>Cyld</term>
<term>Database</term>
<term>December</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatological</term>
<term>Dermatologist</term>
<term>Dermatologists british journal</term>
<term>Dermatology</term>
<term>Dermatology department</term>
<term>Dermatology life quality index</term>
<term>Dermatology patients</term>
<term>Dermis</term>
<term>Disease severity</term>
<term>Dlqi</term>
<term>Durham</term>
<term>Eczema</term>
<term>Eczematoid</term>
<term>Edinburgh</term>
<term>Effective treatment</term>
<term>Epidermal</term>
<term>Epidermal naevus</term>
<term>Erythema</term>
<term>Erythematosus</term>
<term>Erythematous</term>
<term>Etanercept</term>
<term>Excision</term>
<term>Fabry</term>
<term>Fabry disease</term>
<term>Family history</term>
<term>Female patients</term>
<term>Gastroenterologist</term>
<term>General population</term>
<term>General practice</term>
<term>General practitioners</term>
<term>Gpwsis</term>
<term>Guideline</term>
<term>Gvhd</term>
<term>Healthcare</term>
<term>Histoid</term>
<term>Histoid leprosy</term>
<term>Histological</term>
<term>Histology</term>
<term>Histopathological</term>
<term>Histopathology</term>
<term>Hsct</term>
<term>Hyperhidrosis</term>
<term>Imiquimod</term>
<term>Inpatient</term>
<term>Iontophoresis</term>
<term>January</term>
<term>July</term>
<term>Keratinocytes</term>
<term>Keratoacanthoma</term>
<term>Leicester</term>
<term>Leprosy</term>
<term>Lesion</term>
<term>Leukaemia</term>
<term>Lupus</term>
<term>Lyell</term>
<term>Lymphocyte</term>
<term>Lymphoid</term>
<term>Lymphoma</term>
<term>Lymphoproliferative</term>
<term>Macular</term>
<term>Male dermatologists</term>
<term>Malignancy</term>
<term>Malignant</term>
<term>Malignant melanoma</term>
<term>Median</term>
<term>Medical education</term>
<term>Melanoma</term>
<term>Methotrexate</term>
<term>Methylation</term>
<term>Mthfr</term>
<term>Mthfr polymorphism</term>
<term>Mucosal</term>
<term>Multidisciplinary</term>
<term>Multiforme</term>
<term>Mutation</term>
<term>Myotonic</term>
<term>Naevus</term>
<term>Nbuvb</term>
<term>Ndings</term>
<term>Neurological</term>
<term>Neurological disease</term>
<term>Newcastle</term>
<term>Nice guidelines</term>
<term>Nmsc</term>
<term>Node</term>
<term>Nonclinical</term>
<term>Noncutaneous</term>
<term>Noncutaneous malignancies</term>
<term>Northern ireland</term>
<term>November</term>
<term>Outpatient</term>
<term>Pasi</term>
<term>Patient information</term>
<term>Pemphigus</term>
<term>Pemphigus vulgaris</term>
<term>Phenotype</term>
<term>Phototherapy</term>
<term>Placebo</term>
<term>Polymorphism</term>
<term>Poster</term>
<term>Practitioner</term>
<term>Primary care</term>
<term>Psoriasis</term>
<term>Psoriasis area</term>
<term>Psoriatic</term>
<term>Pten</term>
<term>Puva</term>
<term>Rabies</term>
<term>Radiotherapy</term>
<term>Randomized</term>
<term>Rapamycin</term>
<term>Receptor</term>
<term>Recurrence</term>
<term>Referral</term>
<term>Registrar</term>
<term>Relapse</term>
<term>Remission</term>
<term>Renal</term>
<term>Responder</term>
<term>Response rate</term>
<term>Retrospective</term>
<term>Retrospective review</term>
<term>Retrospective study</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatologist</term>
<term>Rituximab</term>
<term>Sarcoidosis</term>
<term>Scalp psoriasis</term>
<term>Sccs</term>
<term>Secondary care</term>
<term>Severe psoriasis</term>
<term>Severity index</term>
<term>Skin biopsies</term>
<term>Skin biopsy</term>
<term>Skin cancer</term>
<term>Skin cancers</term>
<term>Skin disease</term>
<term>Skin lesions</term>
<term>Slnb</term>
<term>Sorafenib</term>
<term>Squamous</term>
<term>Squamous cell carcinoma</term>
<term>Study period</term>
<term>Subungual</term>
<term>Suppl</term>
<term>Surgical</term>
<term>Syndrome</term>
<term>Systemic corticosteroid treatment</term>
<term>Tanning</term>
<term>Tomography</term>
<term>Toxin</term>
<term>Transplantation</term>
<term>Tumour</term>
<term>Tyne</term>
<term>Uctd</term>
<term>Ulceration</term>
<term>University hospital</term>
<term>Vasculitis</term>
<term>Vitiligo</term>
<term>Vulgaris</term>
<term>Vulval</term>
<term>Workload</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abnormality</term>
<term>Acad</term>
<term>Acad dermatol</term>
<term>Acitretin</term>
<term>Acne</term>
<term>Acral</term>
<term>Adalimumab</term>
<term>Adverse pregnancy outcomes</term>
<term>Allergen</term>
<term>Angioma</term>
<term>Antitumour</term>
<term>Assay</term>
<term>Asymptomatic</term>
<term>Audit</term>
<term>Authors journal compilation</term>
<term>Autoantibody</term>
<term>Autoimmune</term>
<term>Axillary</term>
<term>Azathioprine</term>
<term>Basal</term>
<term>Basal cell carcinoma</term>
<term>Basal cell carcinomas</term>
<term>Baseline</term>
<term>Bccs</term>
<term>Belfast</term>
<term>Benign</term>
<term>Biologics</term>
<term>Biopsy</term>
<term>Birthweight</term>
<term>Botulinum</term>
<term>Breslow</term>
<term>Breslow thickness</term>
<term>Bristol</term>
<term>British association</term>
<term>Bullous</term>
<term>Carcinoma</term>
<term>Cardiff</term>
<term>Cardiff university</term>
<term>Caucasian</term>
<term>Cellulitis</term>
<term>Chaperone</term>
<term>Chronic plaque psoriasis</term>
<term>Chronic skin diseases</term>
<term>Clin</term>
<term>Clinic</term>
<term>Clinical diagnosis</term>
<term>Clinical features</term>
<term>Clinician</term>
<term>Cohort</term>
<term>Complete clearance</term>
<term>Consultant dermatologist</term>
<term>Corticosteroid</term>
<term>Counselling</term>
<term>Cutaneous</term>
<term>Cutaneous disease</term>
<term>Cutaneous lymphoma</term>
<term>Cyld</term>
<term>Database</term>
<term>December</term>
<term>Dermatitis</term>
<term>Dermatol</term>
<term>Dermatological</term>
<term>Dermatologist</term>
<term>Dermatologists british journal</term>
<term>Dermatology</term>
<term>Dermatology department</term>
<term>Dermatology life quality index</term>
<term>Dermatology patients</term>
<term>Dermis</term>
<term>Disease severity</term>
<term>Dlqi</term>
<term>Durham</term>
<term>Eczema</term>
<term>Eczematoid</term>
<term>Edinburgh</term>
<term>Effective treatment</term>
<term>Epidermal</term>
<term>Epidermal naevus</term>
<term>Erythema</term>
<term>Erythematosus</term>
<term>Erythematous</term>
<term>Etanercept</term>
<term>Excision</term>
<term>Fabry</term>
<term>Fabry disease</term>
<term>Family history</term>
<term>Female patients</term>
<term>Gastroenterologist</term>
<term>General population</term>
<term>General practice</term>
<term>General practitioners</term>
<term>Gpwsis</term>
<term>Guideline</term>
<term>Gvhd</term>
<term>Healthcare</term>
<term>Histoid</term>
<term>Histoid leprosy</term>
<term>Histological</term>
<term>Histology</term>
<term>Histopathological</term>
<term>Histopathology</term>
<term>Hsct</term>
<term>Hyperhidrosis</term>
<term>Imiquimod</term>
<term>Inpatient</term>
<term>Iontophoresis</term>
<term>January</term>
<term>July</term>
<term>Keratinocytes</term>
<term>Keratoacanthoma</term>
<term>Leicester</term>
<term>Leprosy</term>
<term>Lesion</term>
<term>Leukaemia</term>
<term>Lupus</term>
<term>Lyell</term>
<term>Lymphocyte</term>
<term>Lymphoid</term>
<term>Lymphoma</term>
<term>Lymphoproliferative</term>
<term>Macular</term>
<term>Male dermatologists</term>
<term>Malignancy</term>
<term>Malignant</term>
<term>Malignant melanoma</term>
<term>Median</term>
<term>Medical education</term>
<term>Melanoma</term>
<term>Methotrexate</term>
<term>Methylation</term>
<term>Mthfr</term>
<term>Mthfr polymorphism</term>
<term>Mucosal</term>
<term>Multidisciplinary</term>
<term>Multiforme</term>
<term>Mutation</term>
<term>Myotonic</term>
<term>Naevus</term>
<term>Nbuvb</term>
<term>Ndings</term>
<term>Neurological</term>
<term>Neurological disease</term>
<term>Newcastle</term>
<term>Nice guidelines</term>
<term>Nmsc</term>
<term>Node</term>
<term>Nonclinical</term>
<term>Noncutaneous</term>
<term>Noncutaneous malignancies</term>
<term>Northern ireland</term>
<term>November</term>
<term>Outpatient</term>
<term>Pasi</term>
<term>Patient information</term>
<term>Pemphigus</term>
<term>Pemphigus vulgaris</term>
<term>Phenotype</term>
<term>Phototherapy</term>
<term>Placebo</term>
<term>Polymorphism</term>
<term>Poster</term>
<term>Practitioner</term>
<term>Primary care</term>
<term>Psoriasis</term>
<term>Psoriasis area</term>
<term>Psoriatic</term>
<term>Pten</term>
<term>Puva</term>
<term>Rabies</term>
<term>Radiotherapy</term>
<term>Randomized</term>
<term>Rapamycin</term>
<term>Receptor</term>
<term>Recurrence</term>
<term>Referral</term>
<term>Registrar</term>
<term>Relapse</term>
<term>Remission</term>
<term>Renal</term>
<term>Responder</term>
<term>Response rate</term>
<term>Retrospective</term>
<term>Retrospective review</term>
<term>Retrospective study</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatologist</term>
<term>Rituximab</term>
<term>Sarcoidosis</term>
<term>Scalp psoriasis</term>
<term>Sccs</term>
<term>Secondary care</term>
<term>Severe psoriasis</term>
<term>Severity index</term>
<term>Skin biopsies</term>
<term>Skin biopsy</term>
<term>Skin cancer</term>
<term>Skin cancers</term>
<term>Skin disease</term>
<term>Skin lesions</term>
<term>Slnb</term>
<term>Sorafenib</term>
<term>Squamous</term>
<term>Squamous cell carcinoma</term>
<term>Study period</term>
<term>Subungual</term>
<term>Suppl</term>
<term>Surgical</term>
<term>Syndrome</term>
<term>Systemic corticosteroid treatment</term>
<term>Tanning</term>
<term>Tomography</term>
<term>Toxin</term>
<term>Transplantation</term>
<term>Tumour</term>
<term>Tyne</term>
<term>Uctd</term>
<term>Ulceration</term>
<term>University hospital</term>
<term>Vasculitis</term>
<term>Vitiligo</term>
<term>Vulgaris</term>
<term>Vulval</term>
<term>Workload</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Audit</term>
<term>Base de données</term>
<term>Histologie</term>
<term>Rage</term>
<term>Maladie de la peau</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005C47 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005C47 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:FA24BE2210FD3154DF6E107C23D2011EB826248A |texte= Bristol Cup Posters }}
![]() | This area was generated with Dilib version V0.6.32. | ![]() |